Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,212Revenue $M2,019Net Margin (%)5.6Altman Z-Score3.9
Enterprise Value $M3,858EPS $3.9Operating Margin %8.3Piotroski F-Score7
P/E(ttm)37.2Beneish M-Score-2.5Pre-tax Margin (%)7.2Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %5.3Quick Ratio2.9Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-7.9Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow58.0y-y EBITDA Growth Rate %-2.3ROA % (ttm)3.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with BIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIOKen Fisher 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 143.469%Reduce -2.02%269,075
BIONWQ Managers 2015-12-31 Reduce-0.04%$134.34 - $141.7
($138.69)
$ 143.463%Reduce -4.00%425,876
BIOJoel Greenblatt 2015-12-31 Reduce-0.03%$134.34 - $141.7
($138.69)
$ 143.463%Reduce -21.15%91,287
BIOGeorge Soros 2015-12-31 Sold Out -0.01%$134.34 - $141.7
($138.69)
$ 143.463%Sold Out0
BIOJohn Rogers 2015-12-31 Add0.01%$134.34 - $141.7
($138.69)
$ 143.463%Add 0.58%1,005,947
BIOKen Fisher 2015-12-31 Reduce$134.34 - $141.7
($138.66)
$ 143.463%Reduce -0.32%274,634
BIOMario Gabelli 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 143.463%Reduce -1.76%67,000
BIOPrivate Capital 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 143.463%Reduce -1.87%14,402
BIOJohn Rogers 2015-09-30 Reduce-0.21%$133.19 - $151.93
($144.02)
$ 143.46-0%Reduce -10.94%1,000,161
BIONWQ Managers 2015-09-30 Reduce-0.11%$133.19 - $151.93
($144.02)
$ 143.46-0%Reduce -10.84%443,605
BIOGeorge Soros 2015-09-30 Buy 0.01%$133.19 - $151.93
($144.02)
$ 143.46-0%New holding2,200
BIOJoel Greenblatt 2015-09-30 Reduce-0.01%$133.19 - $151.93
($144.02)
$ 143.46-0%Reduce -6.85%115,771
BIOKen Fisher 2015-09-30 Reduce$133.19 - $151.93
($144.02)
$ 143.46-0%Reduce -3.74%275,519
BIOMario Gabelli 2015-09-30 Reduce$133.19 - $151.93
($144.02)
$ 143.46-0%Reduce -1.02%68,200
BIOJoel Greenblatt 2015-06-30 Reduce-0.18%$134.45 - $151.23
($142.94)
$ 143.460%Reduce -58.42%124,281
BIONWQ Managers 2015-06-30 Reduce-0.04%$134.45 - $151.23
($142.94)
$ 143.460%Reduce -4.66%497,546
BIOJohn Rogers 2015-06-30 Reduce-0.03%$134.45 - $151.23
($142.94)
$ 143.460%Reduce -1.59%1,122,983
BIOPrivate Capital 2015-06-30 Reduce-0.01%$134.45 - $151.23
($142.94)
$ 143.460%Reduce -2.39%14,677
BIOMario Gabelli 2015-06-30 Reduce$134.45 - $151.23
($142.94)
$ 143.460%Reduce -2.13%68,900
BIOKen Fisher 2015-06-30 Reduce$134.45 - $151.23
($142.94)
$ 143.460%Reduce -0.79%286,216
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3822.22view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12019.55view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3920.16view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8523.83view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4125.39view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6228.53view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9328.17view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2227.84view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.627.41view

Press Releases about BIO :

Quarterly/Annual Reports about BIO:

News about BIO:

Articles On GuruFocus.com
Royce 100 Fund Shareholder Letter Sep 20 2015 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 
Different Opinions on Bio-Rad Laboratories Apr 03 2014 

More From Other Websites
Bio-Rad to Report First-Quarter 2016 Financial Results Thursday, May 5, 2016 Apr 13 2016
Bio-Rad to Report First-Quarter 2016 Financial Results Thursday, May 5, 2016 Apr 13 2016
BIO RAD LABORATORIES INC Financials Mar 04 2016
BIO RAD LABORATORIES INC Files SEC form 10-K, Annual Report Feb 29 2016
Bio-Rad Laboratories, Inc. Earnings Analysis: 2015 By the Numbers Feb 29 2016
Edited Transcript of BIO earnings conference call or presentation 25-Feb-16 10:00pm GMT Feb 26 2016
Bio Rad Laboratories Inc Earnings Call scheduled for 5:00 pm ET today Feb 25 2016
BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 25 2016
Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro... Feb 25 2016
Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results Feb 25 2016
Q4 2015 Bio Rad Laboratories Inc Earnings Release - After Market Close Feb 25 2016
CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday,... Feb 16 2016
Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer Feb 08 2016
Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016 Feb 02 2016
Bio-Rad Joins Food Safety Consortium with IBM and Mars, Incorporated Jan 12 2016
Bio-Rad Joins Food Safety Consortium With IBM and Mars, Incorporated Jan 12 2016
Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 11 2016
Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 11 2016
Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters Jan 05 2016
Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters Jan 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)